Literature DB >> 24153138

Eczematous-type multiple drug allergy from isoniazid and ethambutol with positive patch test results.

Esen Özkaya1.   

Abstract

Multiple drug allergy (MDA) is characterized by hypersensitivity to 2 or more chemically unrelated drugs. Multiple drug allergy from simultaneous use of antituberculosis drugs is a rare phenomenon that mainly presents as an urticarial or maculopapular eruption. This case report describes a 58-year-old man who developed a generalized eczematous eruption during the sixth week of oral therapy with 4 antituberculosis drugs-isoniazid, ethambutol, rifampicin, and morphazinamide-for treatment of suspected pleural tuberculosis. The eruption resolved after treatment with systemic corticosteroids and cessation of isoniazid and ethambutol. During a lesion-free period 6 months after cessation of the corticosteroids, patch testing with serial dilutions of isoniazid and ethambutol revealed positive reactions; irritant patch test reactions were excluded by testing with graded concentrations of each drug. The patient avoided the causative drugs and reported no new eruptions at 1-year follow-up. It is important for dermatologists to consider the value of patch testing in determining the causative drugs in suspected cases of eczematous-type MDA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24153138

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  4 in total

1.  High occurrence of simultaneous multiple-drug hypersensitivity syndrome induced by first-line anti-tuberculosis drugs.

Authors:  Da Woon Sim; Hye Su You; Ji Eun Yu; Young-Il Koh
Journal:  World Allergy Organ J       Date:  2021-07-28       Impact factor: 4.084

2.  A retrospective study on sequential desensitization-rechallenge for antituberculosis drug allergy.

Authors:  Bernard Yu-Hor Thong; Faith Li-Ann Chia; Sze-Chin Tan; Teck-Choon Tan; Khai-Pang Leong; Justina Wei-Lyn Tan; Chwee-Ying Tang; Jin-Feng Hou; Grace Yin-Lai Chan; Hiok-Hee Chng
Journal:  Asia Pac Allergy       Date:  2014-07-29

3.  Immediate type hypersensitivity and late phase reaction occurred consecutively in a patient receiving ethambutol and levofloxacin.

Authors:  Yukihiko Kato; Yu Sato; Miho Nakasu; Ryoji Tsuboi
Journal:  Allergy Asthma Clin Immunol       Date:  2018-04-03       Impact factor: 3.406

Review 4.  The Role of Patch Testing in Evaluating Delayed Hypersensitivity Reactions to Medications.

Authors:  Carina M Woodruff; Nina Botto
Journal:  Clin Rev Allergy Immunol       Date:  2022-02-03       Impact factor: 10.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.